Lecanemab trial results herald a new era for Alzheimer’s treatments
Full study data have now been released from the successful trial of the drug "lecanemab" for early Alzheimer's disease. We first heard indications of positive results for lecanemab back in September this year and scientists have been eagerly awaiting the release of the full report.